Experience with the Ross II operation both in developed countries and in patients without a rheumatic disease process has remained low. Our center has previously published the largest experience with the Ross II procedure in North America, and now reports the case with which we have had the longest follow-up. To our knowledge, this is the only reported follow-up of a pulmonary autograft in the mitral position that has functioned well without reintervention for over two decades.
Get full access to this article
View all access options for this article.
References
1.
KabbaniSSRossDNJamilH, et al.Mitral valve replacement with a pulmonary autograft: initial experience. J Heart Valve Dis. 1999;8(4):359-366.
2.
AthanasiouTCherianARossD. The Ross II procedure: pulmonary autograft in the mitral position. Ann Thorac Surg. 2004;78(4):1489-1495.
3.
KabbaniSJamilHNabhaniF, et al.Analysis of 92 mitral pulmonary autograft replacement (Ross II) operations. J Thorac Cardiovasc Surg. 2007;134(4):902-908.
KabbaniSSJamilHHammoudA, et al.Use of pulmonary autograft for mitral replacement: short- and medium-term experience. Eur J Cardiothorac Surg. 2001;20(2):257-261.
6.
BlitzerDHerrmannJLBrownJW. Pulmonary autograft mitral valve replacement (Ross II): long-term follow-up of a US center. World J Pediatr Congenit Heart Surg. 2018;9(6):645-650.
7.
PhuongNChangPStarnesVShinbaneJS. Cardiovascular magnetic resonance of the Ross II procedure: long-term postoperative imaging. World J Pediatr Congenit Heart Surg. 2017;8(3):398-399.
